NAA is considered a marker of functional integrity of neuronal
metabolism. It is synthesized in neuronal mitochondria, catabolized
in oligodendrocytes and it reaches the blood compartment through
the astrocytes. No reports investigating NAA levels both in serum
and in cerebrospinal fluid (CSF) of patients with demyelinating
diseases are available
